May 13, 2026

In the race to deliver curative oncology, data has become simultaneously our most powerful asset and our most critical liability. Artificial intelligence is compressing decades of immunological research into months of computation — yet a systemic failure in data verifiability is preventing those breakthroughs from reaching patients at the speed science now makes possible. Closing […]